Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Opportunities for nanotechnology-based innovation in tissue proteomics.

Geho DH, Lahar N, Ferrari M, Petricoin EF, Liotta LA.

Biomed Microdevices. 2004 Sep;6(3):231-9. Review.

PMID:
15377833
2.

Surface plasmon resonance mass spectrometry: recent progress and outlooks.

Nedelkov D, Nelson RW.

Trends Biotechnol. 2003 Jul;21(7):301-5. Review.

PMID:
12837614
3.

Proteomics: evolution of the technology.

Patterson SD.

Biotechniques. 2003 Sep;35(3):440-4. No abstract available.

PMID:
14513544
4.

Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.

Zhan X, Desiderio DM.

Mass Spectrom Rev. 2005 Nov-Dec;24(6):783-813. Review.

PMID:
15495141
5.

Protein arrays for biomarker discovery.

Reid JD, Parker CE, Borchers CH.

Curr Opin Mol Ther. 2007 Jun;9(3):216-21. Review.

PMID:
17608019
6.

Clinical proteomics and mass spectrometry profiling for cancer detection.

Solassol J, Jacot W, Lhermitte L, Boulle N, Maudelonde T, Mangé A.

Expert Rev Proteomics. 2006 Jun;3(3):311-20. Review.

PMID:
16771703
7.

Nanotechniques in proteomics: current status, promises and challenges.

Ray S, Chandra H, Srivastava S.

Biosens Bioelectron. 2010 Jul 15;25(11):2389-401. doi: 10.1016/j.bios.2010.04.010. Epub 2010 Apr 18. Review.

PMID:
20451366
8.

Proteomics and the haematologist.

Rees-Unwin KS, Morgan GJ, Davies FE.

Clin Lab Haematol. 2004 Apr;26(2):77-86. Review.

PMID:
15053800
9.

Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.

Calvo KR, Liotta LA, Petricoin EF.

Biosci Rep. 2005 Feb-Apr;25(1-2):107-25. Review.

PMID:
16222423
10.

Protein microarrays for cancer diagnostics and therapy.

Lin JC.

Med Princ Pract. 2010;19(4):247-54. doi: 10.1159/000312709. Epub 2010 May 26. Review.

11.

Chips for proteomics: a new tool or just hype?

James P.

Biotechniques. 2002 Dec;Suppl:4-10, 12-3. Review. No abstract available.

PMID:
12514924
12.

Cancer proteomics.

Tan HT, Lee YH, Chung MC.

Mass Spectrom Rev. 2012 Sep-Oct;31(5):583-605. doi: 10.1002/mas.20356. Epub 2012 Mar 15. Review.

PMID:
22422534
13.

High-throughput proteomics using antibody microarrays: an update.

Borrebaeck CA, Wingren C.

Expert Rev Mol Diagn. 2007 Sep;7(5):673-86. Review.

PMID:
17892372
14.

Implications of new proteomics strategies for biology and medicine.

Domon B, Broder S.

J Proteome Res. 2004 Mar-Apr;3(2):253-60. Review.

PMID:
15113101
15.

Mass spectrometry: m/z 1983-2008.

Zhou M, Veenstra T.

Biotechniques. 2008 Apr;44(5):667-8, 670. doi: 10.2144/000112791. Review.

16.

Biochips beyond DNA: technologies and applications.

Ng JH, Ilag LL.

Biotechnol Annu Rev. 2003;9:1-149. Review.

PMID:
14650926
17.

BioMEMS: state-of-the-art in detection, opportunities and prospects.

Bashir R.

Adv Drug Deliv Rev. 2004 Sep 22;56(11):1565-86. Review.

PMID:
15350289
18.

Molecular oncology in the post-genomic era: the challenge of proteomics.

Mocellin S, Rossi CR, Traldi P, Nitti D, Lise M.

Trends Mol Med. 2004 Jan;10(1):24-32. Review. No abstract available.

PMID:
14720583
19.

Protein arrays and their role in proteomics.

Cahill DJ, Nordhoff E.

Adv Biochem Eng Biotechnol. 2003;83:177-87. Review.

PMID:
12934930
20.

Cancer proteomics: Serum diagnostics for tumor marker discovery.

Rai AJ, Chan DW.

Ann N Y Acad Sci. 2004 Jun;1022:286-94. Review.

PMID:
15251974

Supplemental Content

Support Center